20181210-广发证券_香港_-Dim_Sum_Express_4页_636kb
报告摘要
Dim Sum Express Summary
Core Content Overview
The document provides a comprehensive analysis of the performance of various stock indices and sectors in the context of the Hong Kong and mainland Chinese markets, with a focus on 2019 investment outlooks. It includes insights from GF Securities' A/H-share analysts on macroeconomic trends, sector dynamics, and company-specific developments.
Market Performance
| Market | 1D Chg (%) | 1M Chg (%) | YTD Chg (%) | EPS 18E (%) | EPS 19E (%) | P/E 18E | P/E 19E |
|---|---|---|---|---|---|---|---|
| HSI | -0.4 | 1.8 | -12.9 | 33.2 | 10.6 | 10.9 | 9.9 |
| HSCEI | -1.1 | -0.6 | -11.4 | 8.6 | 10.2 | 8.0 | 7.2 |
| MXCN | -0.6 | 2.1 | -17.3 | 38.9 | 14.2 | 11.8 | 10.3 |
| SHSZ300 | 0.0 | 0.4 | -21.1 | 29.4 | 14.2 | 11.1 | 9.8 |
| SHCOMP | 0.0 | 0.3 | -21.2 | 34.1 | 12.2 | 10.7 | 9.5 |
| SZCOMP | 0.0 | 1.7 | -28.9 | 67.1 | 21.6 | 15.6 | 12.8 |
| INDU | -2.2 | -6.2 | -1.3 | 48.2 | 8.8 | 15.3 | 14.0 |
| SPX | -2.3 | -5.3 | -1.5 | 50.3 | 8.8 | 16.1 | 14.8 |
| CCMP | -3.0 | -5.9 | 1.0 | 80.5 | 13.1 | 20.4 | 18.1 |
| UKX | 1.1 | -4.6 | -11.8 | 175.9 | 7.2 | 12.0 | 11.2 |
| NKY | 0.8 | -2.6 | -4.8 | 63.1 | 12.7 | 15.6 | 13.9 |
Key Investment Views
2019 H-Share Strategy Outlook
- 2018 Review: Liquidity pressures, economic downturn, and renminbi depreciation affected H-share valuations and EPS estimates.
- 2019 Expectations:
- US economy and stock market may decline, and Fed may delay rate hikes.
- Weaker renminbi and stronger USD could ease upward pressure on US bond yields, improving cross-border liquidity.
- HSI EPS growth expected at ~2.5% in 2019 under base case.
- Structural reforms will support moderate valuation growth.
- Short-term risks remain, but the market is expected to improve after 2Q19.
- Recommendations:
- Overweight: Consumer services, insurance, auto sectors.
- Overweight: Consumer and tech leaders with high dollar-denominated costs.
- Overweight: Infrastructure construction sector.
- Overweight: Hong Kong local leaders with high dividends.
Sector Analysis
Pharmaceuticals
- Price Negotiation: Completed on Dec 6, with significant price reductions for certain drugs.
- Impact: Successful bidders saw prices drop by 92% and 44%, respectively.
- Uncertainties: Pilot scheme may not be expanded nationwide.
- Outlook: Generic drugs may peak, and competition could deteriorate. R&D efficiency in generics is crucial, and the trend of generics + innovation is expected.
Steel
- Supply-Demand Dynamics: Weak in Nov due to seasonal demand decline and high capacity utilization.
- Valuation: P/E at 6.03x TTM, P/B at 1.03x LF, indicating low valuations.
- Outlook: Sector fundamentals may worsen in Dec. Prices will face pressure, but profitability could recover due to upstream price shifts and reduced production.
Electrical Equipment
- Infrastructure and Intelligent Manufacturing: Expected to benefit the sector.
- Power Trends: Rising power consumption and increasing share of new energy in grid and consumption.
- Sub-Sectors: UHV transmission and power distribution networks are booming.
- Recommendations: Watch Inovance, Hongfa Technology, Nari Technology, Pinggao Electric, and Xuji Electric.
Wind Power and Solar Power
- Wind Power: Bidding prices for 2MW turbines fell from Rmb3,700/kW to Rmb3,200/kW.
- PV Capacity: Global PV capacity to reach ~120GW, up 20% YoY; China's to reach 45GW.
- Technological Drivers: Lower-cost silicon, PERC batteries, and module packaging tech will drive structural growth and enable grid parity sooner.
Textile & Apparel
- Trade Tensions: Risks from Sino-US trade tensions and FX/cotton price impacts on GPM.
- Regional Advantage: Southeast Asian countries have cost advantages and improving industrial chains.
- Outlook: E-commerce revenue growth is expected to outpace offline channels over the next two years.
Computer
- Innovation Stage: Sector is in a take-off phase for innovative products and services.
- Growth Prospects: Stronger counter-cyclical characteristics due to rapid penetration.
- Recommendation: Overweight stance on the sector.
Basic Chemicals
- Price Pressure: Chemical prices under downward pressure due to falling crude oil prices.
- Valuation: P/E at 15.16x TTM, lower than the average since 2012.
- Investment Themes:
- Sub-sectors with stable demand or upcycle (phoschemical, natural gas, agricultural chemicals).
- New materials with promising development (auto-exhaust catalyst, OLED materials, lithium batteries).
- Sector leaders benefiting from industry reshaping.
- Stock Picks: Valiant, Sinocera, Phichem, Hualu-Hengsheng, Yangnong Chemical, Jinhe Industrial.
Company Highlights
Peacebird Fashion (603877 CH)
- Share Transfer: Controlling shareholder Proven transferred shares to associates, avoiding secondary market pressure.
- Financial Estimates: EPS of Rmb1.35/1.70/2.11 for 2018/19/20; P/E of 13/11/8x; PEG < 1x.
- Rating: Maintain Buy.
Kweichow Moutai (600519 CH)
- Pricing Power: Strong brand gives pricing power in the baijiu sector.
- Growth Estimates: High-end baijiu spending to grow at CAGR of 10–15% (personal), 5–10% (business), and 0% (government).
- Sector Growth: Baijiu sector revenue growth at ~10% CAGR.
- Sales and Price: Moutai wine sales and per tonne prices to grow at CAGR of 5% and 8%, respectively.
- Financial Estimates: EPS of Rmb26.82/30.82/38.14; P/E of 22/19/15x.
- Rating: Maintain Buy.
Rating Definitions
-
Buy: Stock expected to outperform benchmark by >15%
-
Accumulate: Stock expected to outperform benchmark by 5–15%
-
Hold: Expected stock relative performance between -5% and 5%
-
Underperform: Stock expected to underperform benchmark by >5%
-
Sector Ratings:
- Positive: Sector expected to outperform benchmark by >10%
- Neutral: Expected sector relative performance between -10% and 10%
- Cautious: Sector expected to underperform benchmark by >10%
Disclaimer
- This report is for informational purposes only and does not constitute an offer to buy or sell securities.
- GF Securities (Hong Kong) accepts no liability for losses arising from the use of this report.
- Investment involves risks and past performance does not guarantee future results.
- The report is not a substitute for professional advice.
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载